Seaview Investment Managers LLC Takes $425,000 Position in Colgate-Palmolive (NYSE:CL)

Seaview Investment Managers LLC acquired a new stake in Colgate-Palmolive (NYSE:CLFree Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 4,381 shares of the company’s stock, valued at approximately $425,000.

Several other large investors have also made changes to their positions in the business. Union Savings Bank lifted its stake in shares of Colgate-Palmolive by 76.6% in the 4th quarter. Union Savings Bank now owns 309 shares of the company’s stock valued at $25,000 after purchasing an additional 134 shares during the period. E Fund Management Hong Kong Co. Ltd. acquired a new position in Colgate-Palmolive during the second quarter worth $25,000. Atlantic Edge Private Wealth Management LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth $32,000. PSI Advisors LLC raised its position in Colgate-Palmolive by 4,971.4% during the first quarter. PSI Advisors LLC now owns 355 shares of the company’s stock worth $32,000 after acquiring an additional 348 shares during the period. Finally, Core Wealth Advisors Inc. raised its position in shares of Colgate-Palmolive by 56.6% in the fourth quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after buying an additional 146 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Colgate-Palmolive

In other news, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares in the company, valued at approximately $1,439,929.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the transaction, the insider now owns 13,942 shares in the company, valued at approximately $1,439,929.76. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Panagiotis Tsourapas sold 14,794 shares of the company’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the completion of the transaction, the insider now directly owns 5,146 shares in the company, valued at $529,729.24. The disclosure for this sale can be found here. In the last quarter, insiders sold 43,490 shares of company stock worth $4,486,063. 0.34% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of recent research reports. Citigroup increased their target price on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Sanford C. Bernstein increased their target price on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research report on Tuesday, July 30th. BNP Paribas assumed coverage on shares of Colgate-Palmolive in a research report on Monday, June 24th. They issued an “outperform” rating and a $109.00 target price for the company. UBS Group upped their price objective on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Finally, Argus increased their target price on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research note on Wednesday, May 15th. Nine analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $102.63.

Get Our Latest Report on CL

Colgate-Palmolive Trading Down 0.7 %

NYSE CL opened at $107.11 on Tuesday. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $109.30. The company has a 50-day moving average of $101.30 and a 200-day moving average of $94.73. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. The company has a market cap of $87.52 billion, a P/E ratio of 33.90, a P/E/G ratio of 3.78 and a beta of 0.40.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The company had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. During the same quarter in the prior year, the company posted $0.77 EPS. The company’s quarterly revenue was up 4.9% compared to the same quarter last year. As a group, equities analysts predict that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.87%. The ex-dividend date was Friday, July 19th. Colgate-Palmolive’s payout ratio is currently 63.29%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.